CareDx, Inc. (NASDAQ: CDNA)
$20.6500
+0.0400 ( 0% ) 296.6K
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
Market Data
Open
$20.6500
Previous close
$20.6100
Volume
296.6K
Market cap
$1.13B
Day range
$20.4030 - $21.4800
52 week range
$7.4200 - $34.8400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 18, 2024 |
3 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 10, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
4 | Insider transactions | 1 | May 16, 2024 |
8-k | 8K-related | 32 | May 09, 2024 |
10-q | Quarterly Reports | 87 | May 09, 2024 |
3 | Insider transactions | 1 | May 03, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |